1
Reactions 1207 - 21 Jun 2008 Many prescribers may not recognise potentially harmful drug-drug interactions, according to results from a survey conducted in the US. Prescribers were asked to classify 14 drug pairs as "should not be used together", "may be used together but with monitoring", "no interaction" or "not sure". Nine hundred and fifty prescribers responded to the survey. On average, < 50% of the drug pairs were correctly classified by respondents. Among contraindicated drug pairs, only sildenafil and isosorbide mononitrate was correctly classified by the majority of respondents (80.7%). Most respondents used printed materials (24.1%) or personal digital assistants (25.9%) for information on drug-drug interactions. Prescribers reported that they were usually informed about drug-drug interactions by the pharmacist. Ko Y, et al. Prescribers’ knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Safety 31: 525-536, No. 6, 2008 801089259 1 Reactions 21 Jun 2008 No. 1207 0114-9954/10/1207-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Many prescribers may not recognise potentially harmful drug-drug interactions

  • Upload
    hanhan

  • View
    212

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Many prescribers may not recognise potentially harmful drug-drug interactions

Reactions 1207 - 21 Jun 2008

■ Many prescribers may not recognise potentiallyharmful drug-drug interactions, according to resultsfrom a survey conducted in the US. Prescribers wereasked to classify 14 drug pairs as "should not be usedtogether", "may be used together but with monitoring","no interaction" or "not sure". Nine hundred and fiftyprescribers responded to the survey. On average,< 50% of the drug pairs were correctly classified byrespondents. Among contraindicated drug pairs, onlysildenafil and isosorbide mononitrate was correctlyclassified by the majority of respondents (80.7%).Most respondents used printed materials (24.1%) orpersonal digital assistants (25.9%) for information ondrug-drug interactions. Prescribers reported that theywere usually informed about drug-drug interactions bythe pharmacist.Ko Y, et al. Prescribers’ knowledge of and sources of information for potentialdrug-drug interactions: a postal survey of US prescribers. Drug Safety 31:525-536, No. 6, 2008 801089259

1

Reactions 21 Jun 2008 No. 12070114-9954/10/1207-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved